Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing...

Area of Science:

• Infectious Diseases
• Pharmacology
• Immunology

Background:

• The clinical impact of varying endotoxin-liberating potentials among antibiotics is not well understood.
• Endotoxins, components of Gram-negative bacterial cell walls, can trigger severe inflammatory responses.

Purpose of the Study:

• To investigate the clinical significance of differences in endotoxin release between imipenem (low potential) and ceftazidime (high potential) in patients with Gram-negative urosepsis.
• To compare the effects of these antibiotics on endotoxin levels, fever resolution, and cytokine responses.

Main Methods:

• A randomized trial involving 30 patients with Gram-negative urosepsis, comparing imipenem and ceftazidime treatment.
• Measurement of blood and urine endotoxin levels, body temperature, and serum/urine cytokine levels at baseline and after 4 hours of treatment.
• In vitro assessment of endotoxin release by various microorganisms exposed to both antibiotics.

Main Results:

• Ceftazidime treatment was associated with slower defervescence (fever reduction) compared to imipenem.
• Blood endotoxin levels decreased in imipenem-treated patients but increased in some ceftazidime-treated patients after 4 hours.
• Serum and urine cytokine levels showed a significant increase with ceftazidime but not imipenem.
• In vitro studies demonstrated a 10-fold higher endotoxin release with ceftazidime compared to imipenem.

Conclusions:

• Differences in antibiotic-induced endotoxin release may influence the inflammatory response in patients with Gram-negative urosepsis.
• Imipenem may be associated with a more favorable endotoxin profile and inflammatory response compared to ceftazidime in this context.